Skip to main content
. 2019 Nov 29;7:333. doi: 10.1186/s40425-019-0824-5

Table 2.

Main molecular alterations in HCC according to molecular subtypes adapted from the Cancer Genome Atlas Research Network [40]

Molecular subtype Genetic features Epigenetic features Other characteristics

iCluster 1

36%

Few CTNNB1 mutations

Low expression of TERT

Overexpression of proliferation markers

microRNA signature

mir-122 silencing

High expression of miR-181A

Young age

Asian patients

Female patients

Normal Weight

High grade

Poor prognosis

iCluster 2

30%

High expression of TERT

High expression of CTNNB1

HNF1A mutations

CDKN2A silencing

Low grade

Low microvascular invasion

iCluster 3

34%

Chromosomal instability

17p loss

TP53 mutations

High activation of CTNNB1

High expression of TERT

Activation of VEGF-A pathway

PTEN inactivation

CDKN2A silencing

CPG Island hypomethylation

Frequencies of most prevalent alterations in the whole cohort

TERT mutations 44%

TP53 mutations 31%

CTNNB1 mutations 27%

CDKN2A deletion 13%

APOB mutations 10%

AXIN1 mutations 8%

ARID1A mutations 7%

CDKN2A silencing 54%